Nuveen New Jersey Quality Municipal Income Fund (NXJ)
Apr 27, 2026 - NXJ was delisted (reason: merged into NMZ)
12.41
+0.02 (0.16%)
Inactive · Last trade price on Apr 24, 2026

NXJ Balance Sheet

Millions USD. Fiscal year is Sep - Aug.

Assets

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '25 Feb '25 Feb '24 Feb '23 Feb '22
Cash & Equivalents
0.2--8.162.7
Cash & Short-Term Investments
0.2--8.162.7
Cash Growth
---201.97%-2.99%
Receivables
9.4214.4721.559.269.53
Total Current Assets
9.6214.4721.5517.4112.23
Long-Term Investments
874.47917.97926.62865.18958
Other Long-Term Assets
1.850.0918.820.8721.82
Total Assets
885.95932.53966.97903.46992.06

Liabilities

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '25 Feb '25 Feb '24 Feb '23 Feb '22
Accounts Payable
--14.280.98-
Accrued Expenses
1.091.641.111.160.92
Short-Term Debt
376.68379.87377.63345.92346.53
Other Current Liabilities
2.9631.321.222.17
Total Current Liabilities
380.73384.51394.35349.27349.62
Total Liabilities
380.73384.51394.35349.27349.62

Shareholders' Equity

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '25 Feb '25 Feb '24 Feb '23 Feb '22
Common Stock
0.410.410.410.410.41
Additional Paid-In Capital
559.29581.57587.74591.79591.85
Retained Earnings
-54.48-33.96-15.53-38.0250.17
Shareholders' Equity
505.22548.02572.62554.19642.44
Total Liabilities & Equity
885.95932.53966.97903.46992.06

Additional Metrics

Fiscal Year
FY 2025FY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '25 Feb '25 Feb '24 Feb '23 Feb '22
Total Debt
376.68379.87377.63345.92346.53
Net Cash (Debt)
-376.48-379.87-377.63-337.76-343.83
Net Cash Growth
-----
Net Cash Per Share
--9.21-9.16-8.14-8.29
Filing Date Shares Outstanding
41.2341.2341.2341.4841.48
Total Common Shares Outstanding
41.2341.2341.2341.4841.48
Working Capital
-371.11-370.04-372.79-331.86-337.39
Book Value Per Share
12.2513.2913.8913.3615.49
Tangible Book Value
505.22548.02572.62554.19642.44
Tangible Book Value Per Share
12.2513.2913.8913.3615.49
SEC Filings: 10-K · 10-Q